HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunogenicity and safety of virus-like particle of the porcine encephalomyocarditis virus in pig.

AbstractBACKGROUND:
In this study, porcine encephalomyocarditis virus (EMCV) virus-like particles (VLPs) were generated using a baculovirus expression system and were tested for immunogenicity and protective efficacy in vivo.
RESULTS:
VLPs were successfully generated from Sf9 cells infected with recombinant baculovirus and were confirmed to be approximately 30-40 nm by transmission electron microscopy (TEM). Immunization of mice with 0.5 μg crude protein containing the VLPs resulted in significant protection from EMCV infection (90%). In swine, increased neutralizing antibody titers were observed following twice immunization with 2.0 μg crude protein containing VLPs. In addition, high levels of neutralizing antibodies (from 64 to 512 fold) were maintained during a test period following the second immunization. No severe injection site reactions were observed after immunization and all swine were healthy during the immunization period.
CONCLUSION:
Recombinant EMCV VLPs could represent a new vaccine candidate to protect against EMCV infection in pig farms.
AuthorsHye-Young Jeoung, Won-Ha Lee, WooSeog Jeong, Bo-Hye Shin, Hwan-Won Choi, Hee Soo Lee, Dong-Jun An
JournalVirology journal (Virol J) Vol. 8 Pg. 170 (Apr 15 2011) ISSN: 1743-422X [Electronic] England
PMID21492483 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • Viral Proteins
Topics
  • Animals
  • Antibodies, Viral (immunology)
  • Cardiovirus Infections (immunology, veterinary, virology)
  • Cell Line
  • Drug-Related Side Effects and Adverse Reactions
  • Encephalomyocarditis virus (genetics, immunology, physiology, ultrastructure)
  • Female
  • Immunization (adverse effects)
  • Mice
  • Mice, Inbred BALB C
  • Microscopy, Electron, Transmission
  • Spodoptera
  • Swine
  • Swine Diseases (immunology, virology)
  • Viral Proteins (administration & dosage, adverse effects, genetics, immunology)
  • Virion (genetics, immunology, physiology, ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: